PharVision Advisers’s Scorpio Tankers STNG Stock Holding History

PharVision Advisers’s Portfolio STNG Stock Details STNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,685	Closed	-$319K	–	990
2025 Q3	$319K	Buy	+5,685	New	+$280K	0.18%	192

Other funds holding STNG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

PharVision Advisers's STNG Position: Q4 2025 in Review

PharVision Advisers sold out of Scorpio Tankers (STNG) in Q4 2025, closing a stake of 5,685 shares — an estimated $319K sold.

PharVision Advisers first reported a position in STNG in Q3 2025 and held it in 1 quarter. The position peaked at $319K in Q3 2025. 271 funds tracked by Wall St. Rank hold STNG as of Q4 2025.

PharVision Advisers reported no remaining Scorpio Tankers position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 5,685 Scorpio Tankers shares in Q4 2025, an estimated $319K.
PharVision Advisers first reported a position in Scorpio Tankers in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Scorpio Tankers position peaked at $319K in Q3 2025.
271 funds tracked by Wall St. Rank held Scorpio Tankers as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.